Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
15.20
+0.15 (1.00%)
At close: Sep 26, 2025, 4:00 PM EDT
15.03
-0.17 (-1.12%)
After-hours: Sep 26, 2025, 6:38 PM EDT

Oruka Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Oruka Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $43, which forecasts a 182.89% increase in the stock price over the next year. The lowest target is $20 and the highest is $56.

Price Target: $43 (+182.89%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$20$43$45$56
Change+31.58%+182.89%+196.05%+268.42%

Analyst Ratings

The average analyst rating for Oruka Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy444455
Buy344442
Hold000000
Sell000000
Strong Sell000000
Total788897

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Maintains
$44$56
Strong BuyMaintains$44$56+268.42%Sep 17, 2025
Clear Street
Clear Street
Strong Buy
Maintains
$46
Strong BuyMaintains$46+202.63%Sep 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$45
Strong BuyReiterates$45+196.05%Aug 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$45
Strong BuyReiterates$45+196.05%Jul 23, 2025
Wedbush
Wedbush
Buy
Reiterates
$40
BuyReiterates$40+163.16%May 15, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.25
from -4.23
EPS Next Year
-2.67
from -2.25
Fiscal YearFY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
----
Revenue Growth
----
EPS
-4.23-2.25-2.67-2.53
EPS Growth
----
Forward PE
----
No. Analysts
-11105
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027
High--
Avg--
Low--

EPS Forecast

EPS202520262027
High-1.79-1.98
Avg-2.25-2.67
Low-2.61-3.32

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.